WASHINGTON — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65.
The announcement Monday from the Food and Drug Administration…

WASHINGTON — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65.
The announcement Monday from the Food and Drug Administration…

New research from the University of Virginia School of Medicine is revealing why traumatic brain injury increases the chance of developing Alzheimer’s disease – and the discovery is pointing to a potential strategy to prevent…

Growing evidence suggests that getting cozy with soil microbes, especially as kids, can guard against allergic disease. Credit: Jenna Stensland
Researcher contact:
Joshua Ladau, Arva Intelligence, [email protected] (UTC-8 hours)
AGU press…

Patients with newly diagnosed advanced ovarian cancer who experienced disease progression had worse health-related quality of life (HRQOL), according to data from the PRIMA/ENGOT-OV26/GOG-3012 trial of first-line maintenance therapy with…

The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists…

If you spend any time in a memory clinic or stroke unit, you can feel it in the room: neurologic disease rarely arrives alone. It brings isolation, late-night worry, and long stretches of time where nothing happens but waiting. We now know that…

If administered before infection,

Pharmacy Times: At SABCS, Agendia is presenting multiple posters demonstrating how MammaPrint and BluePrint can guide treatment decisions, including the use—or avoidance—of anthracycline therapy. What do you view as the most clinically…

Quick Takes